Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco / Pavithra Viswanath, PhD |
Innovation Grants |
2024 |
California |
The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
Targeting of a putative unresolved wound healing process in childhood ependymoma |
University of Colorado Denver / Nicholas Foreman, MD |
Innovation Grants |
2024 |
Colorado |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma |
St. Jude Children’s Research Hospital / Ian Delahunty, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Modifying CAR T cell epigenetic programs to improve therapy against aggressive pediatric brain tumors |
St. Jude Children’s Research Hospital / Meghan Ward, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma |
Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
The influence of the raphe nucleus and serotonin on progression of diffuse intrinsic pontine glioma |
Stanford University / Richard Drexler, MD/PhD |
Young Investigator Grants |
2024 |
California |